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Background: Pediatric dilated cardiomyopathy (DCM) carries a poor prognosis, with LV dysfunction at presentation known to predict death or 
cardiac transplant. However the relationship of progressive LV dilation and wall thinning to outcome is unknown.
Methods: The PCMR enrolled >3000 children (0-18 yrs) from North America with cardiomyopathy from 1990-2005 and monitored the 
echocardiographic progression of disease and outcomes of these patients. In those with isolated DCM, we evaluated changes in the z-score adjusted 
LV fractional shortening (LVFS), LV diastolic dimension (LVDD), and LV posterior wall thickness (h) at baseline and for up to 12 months after, 
measuring the interval change noted in patients who survived, died or who were transplanted. We determined the ongoing hazard ratio for death or 
transplantation after 12 months using both the baseline data, and the interval change seen from 0-12 months.
Results: Of 1457 DCM patients, 1043 survived to 12 months, 140 (9.6%) died and 274 (18.8%) were transplanted. The survivor group had 
a higher baseline LVFS, which improved with time (p<0.01), and a lower baseline LVDD z-score (4.2 vs 5.8 p<0.001). The survivors also had a 
decrease in median LVDD z-score of 1.4 SD (p<0.001), over the first 12 months compared to an increase of 0.7 SD in those who died (p<0.001). 
While baseline wall thickness did not differ, the ratio to LV dimension (h/LVDD) tended to decrease in those who died or were transplanted, and 
increase in survivors. Of the 425 children who were event-free at 12 months, a further 89 (21%) later died or underwent transplantation. In a Cox 
regression analysis, the hazard ratio (HR) for death or transplantation beyond 1 year was predicted by a decrease in h/LVDD (0.50, p<0.03) and in 
multivariable modeling by a reduction in LVFS over time (0.82, p<0.001), and also by an increase in LVDD (1.27, p<0.01) during the first year after 
the diagnosis.
Conclusion: In addition to a low baseline and progressive reduction in LVFS, increasing LVDD and wall thinning may be important predictors of 
outcome for children with DCM. This evidence of progressive dilation and remodeling should be taken into account when determining the treatment 
plan for children with isolated DCM.
